Login to Your Account



Circle Pharma's work with Pfizer yields new macrocyclic peptides

By Michael Fitzhugh
Staff Writer

Thursday, January 18, 2018

Circle Pharma Inc., of South San Francisco, said its first collaboration with Pfizer Inc. has led to the identification of a series of bioavailable macrocyclic peptides capable of acting as potent and cell-permeable modulators of CXCR7.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription